David Michael Johnson insider trades

Open-market stock purchases and sales by David Michael Johnson, Director at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 7, 2020.

Track record: 10% of 20 scored buys are up 5% or more since purchase, averaging -32%.

Recent trades

DateStockTradeValue
Jun 16, 2026ZNTL Zentalis Pharmaceuticals, IncBought (not open market)—
Jun 11, 2026AURA Aura Biosciences, IncBought (not open market)—
Jun 11, 2026AURA Aura Biosciences, IncBought (not open market)—

Companies traded

  • ZNTL Zentalis Pharmaceuticals, Inc: 2 buys, 8 sales, last Jun 16, 2026
  • AURA Aura Biosciences, Inc: 18 buys, last Jun 11, 2026

Get free alerts when David Michael Johnson files a new trade →